67 related articles for article (PubMed ID: 9472696)
1. Antisense RNA-mediated reduction of p53 induces malignant phenotype in nontumorigenic rat urothelial cells.
Okamoto M; Hattori K; Fujimoto K; Tanaka Y; Gloosby CL; Oyasu R
Carcinogenesis; 1998 Jan; 19(1):73-9. PubMed ID: 9472696
[TBL] [Abstract][Full Text] [Related]
2. FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma.
Zhou H; He F; Mendelsohn CL; Tang MS; Huang C; Wu XR
Sci Rep; 2016 May; 6():25596. PubMed ID: 27157475
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
[TBL] [Abstract][Full Text] [Related]
4. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
[TBL] [Abstract][Full Text] [Related]
5. Transformation of human urothelial cells (UROtsa) by as and cd induces the expression of keratin 6a.
Somji S; Bathula CS; Zhou XD; Sens MA; Sens DA; Garrett SH
Environ Health Perspect; 2008 Apr; 116(4):434-40. PubMed ID: 18414623
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.
He F; Mo L; Zheng XY; Hu C; Lepor H; Lee EY; Sun TT; Wu XR
Cancer Res; 2009 Dec; 69(24):9413-21. PubMed ID: 19951992
[TBL] [Abstract][Full Text] [Related]
7. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.
Yang J; Platt LT; Maity B; Ahlers KE; Luo Z; Lin Z; Chakravarti B; Ibeawuchi SR; Askeland RW; Bondaruk J; Czerniak BA; Fisher RA
Oncotarget; 2016 Oct; 7(43):69159-69172. PubMed ID: 27713144
[TBL] [Abstract][Full Text] [Related]
8. The urothelial cell line UROtsa transformed by arsenite and cadmium display basal characteristics associated with muscle invasive urothelial cancers.
Hoggarth ZE; Osowski DB; Freeberg BA; Garrett SH; Sens DA; Sens MA; Zhou XD; Zhang KK; Somji S
PLoS One; 2018; 13(12):e0207877. PubMed ID: 30550540
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathways of urothelial development and bladder tumorigenesis.
Castillo-Martin M; Domingo-Domenech J; Karni-Schmidt O; Matos T; Cordon-Cardo C
Urol Oncol; 2010; 28(4):401-8. PubMed ID: 20610278
[TBL] [Abstract][Full Text] [Related]
10. Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors.
Schallenberg S; Plage H; Hofbauer S; Furlano K; Weinberger S; Bruch PG; Roßner F; Elezkurtaj S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Horst D; Klatte T; Schlomm T; Zecha H
Acta Oncol; 2023 Dec; 62(12):1880-1889. PubMed ID: 37938166
[TBL] [Abstract][Full Text] [Related]
11. Alterations of p53 and Rb Pathways Are Associated with High Proliferation in Bladder Urothelial Carcinomas.
Goussia AC; Papoudou-Bai A; Charchanti A; Kitsoulis P; Kanavaros P; Kalef-Ezra J; Stefanou D; Agnantis NJ
Anticancer Res; 2018 Jul; 38(7):3985-3988. PubMed ID: 29970521
[TBL] [Abstract][Full Text] [Related]
12. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C
Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.
Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ
J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128
[TBL] [Abstract][Full Text] [Related]
14. Comparison of expression patterns of keratin 6, 7, 16, 17, and 19 within multiple independent isolates of As(+3)- and Cd (+2)-induced bladder cancer : keratin 6, 7, 16, 17, and 19 in bladder cancer.
Somji S; Cao L; Mehus A; Zhou XD; Sens MA; Dunlevy JR; Garrett SH; Zheng Y; Larson JL; Sens DA
Cell Biol Toxicol; 2011 Dec; 27(6):381-96. PubMed ID: 21927821
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas.
He F; Melamed J; Tang MS; Huang C; Wu XR
Cancer Res; 2015 May; 75(10):2017-28. PubMed ID: 25795707
[TBL] [Abstract][Full Text] [Related]
16. [Current knowledge in molecular pathology of urothelial cancer].
Knüchel-Clarke R; Dahl E; Gaisa NT; Schwamborn K; Lindemann-Docter K; Henkel C
Pathologe; 2010 Oct; 31 Suppl 2():234-8. PubMed ID: 20665023
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated transfer of p53 and p16 inhibiting proliferating activity of human bladder cancer cell EJ in vitro and in vivo.
Zhu Z; Xing S; Lin C; Zeng F; Lu G; Fu M; Zhang X; Liang X; Wu M
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):324-6. PubMed ID: 12674770
[TBL] [Abstract][Full Text] [Related]
18. ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression.
Fujii T; Shimada K; Anai S; Fujimoto K; Konishi N
Cancer Sci; 2013 Mar; 104(3):321-7. PubMed ID: 23279696
[TBL] [Abstract][Full Text] [Related]
19. Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.
Cao L; Zhou XD; Sens MA; Garrett SH; Zheng Y; Dunlevy JR; Sens DA; Somji S
J Appl Toxicol; 2010 Jul; 30(5):416-30. PubMed ID: 20186695
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle control and DNA damage response of conditionally immortalized urothelial cells.
Dixon BP; Henry J; Siroky BJ; Chu A; Groen PA; Bissler JJ
PLoS One; 2011 Jan; 6(1):e16595. PubMed ID: 21305048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
